Figures
Abstract
Objective
To compare maternal and neonatal outcomes in women with a previous history of pregnancy loss and/or preterm delivery who underwent ultrasound-indicated cerclage (UIC) or history-indicated cerclage (HIC).
Methods
PubMed, Web of Science, Scopus, and Embase databases were searched for observational studies and randomized controlled trials (RCT) from inception to 30 April 2024. Eligible studies should have compared the outcomes of women with singleton pregnancies who underwent UIC or HIC. STATA version 15.0 was employed, and the analysis was done using a random effects model and unadjusted effect sizes from the included studies.
Results
Of 25 included studies (n = 3909), most (n = 18) were retrospective cohort studies. Compared to women who underwent HIC, UIC was associated with higher risk of having a preterm birth (<37 weeks of gestation) (OR 1.48, 95% CI: 1.17, 1.88; N = 15), low birth weight (<2500g) (OR 1.78, 95% CI: 1.32, 2.41; N = 6) and admission to neonatal intensive care unit (OR 1.70, 95% CI: 1.27, 2.27; N = 6,). Women with UIC also had a higher risk of chorioamnionitis (OR 2.34, 95% CI: 1.36, 4.04; N = 4). The risk of having a low APGAR score (5-minute score of less than 7), fetal death and preterm premature rupture of membrane (PPROM) was comparable among the two groups.
Conclusion
Our results demonstrate that UIC is associated with higher risks of adverse pregnancy outcomes compared to HIC. However, our evidence emanates from observational studies and is prone to biases, particularly because the findings were unadjusted for potential confounders. More clinical trials are needed to confirm our observations.
Citation: Wang J, Zhu L, Xu C, Wu W, Shen X (2025) Comparison of pregnancy outcomes after history-indicated and ultrasound-indicated cervical cerclage: A systematic review and meta-analysis. PLoS One 20(8): e0328564. https://doi.org/10.1371/journal.pone.0328564
Editor: Athanasios G. Pantelis, Athens Medical Group, Psychiko Clinic, GREECE
Received: November 18, 2024; Accepted: July 3, 2025; Published: August 14, 2025
Copyright: © 2025 Wang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the paper and its Supporting Information files.
Funding: The author(s) received no specific funding for this work.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Cervical cerclage is a surgical intervention commonly used to prevent preterm birth in women at high risk of cervical insufficiency [1,2]. This procedure involves the placement of sutures around the cervix to reinforce it and prevent premature dilation. Two primary indications for cervical cerclage are history-indicated cerclage (HIC), based on a patient’s obstetric history, and ultrasound-indicated cerclage (UIC), determined by ultrasonographic evidence of cervical shortening during pregnancy [2]. While cervical cerclage has been shown to reduce the risk of preterm birth and perinatal mortality efficiently [3], the decision to perform a procedure based on historical factors versus ultrasound findings remains a topic of considerable clinical interest and debate [4]. HIC is typically recommended for women with a history of second-trimester losses or preterm births attributed to painless cervical dilation [2,5]. Conversely, UIC is performed when a significant shortening of the cervix is observed via transvaginal ultrasound, often identified during routine mid-trimester scans [2,5].
Given the differences in indications and timing for these two approaches, it is essential to evaluate and compare their effectiveness in improving pregnancy outcomes. A previous review by Berghella et al.[6] compared pregnancy outcomes of women with singleton pregnancies and a history of preterm birth that had either cerclage placed after cervical length screening or HIC. The review included 4 randomized trials (n = 476 subjects) and showed both approaches were associated with comparable rates of preterm birth and perinatal mortality [6]. The review concluded that singleton pregnancies in women with a history of preterm birth can be safely monitored with transvaginal ultrasound cervical length screening rather than routine HIC. However, the review included small number of studies, focused on limited outcomes and did not take into account non-randomized studies that utilized cohort-based data [6]. Another systematic review by Blikman et al included 6 studies and compared pregnancy outcomes in patients at risk of cervical insufficiency who received either UIC or HIC [7]. Five out of 6 included studies did not report differences in pregnancy outcomes (preterm birth or pregnancy loss <24 weeks) between the two groups. However, as new studies on the subject have been conducted since the publication of these reviews, there is a need for an updated review of contemporary data.
This study aims to conduct an updated systematic review of the literature comparing HIC and UIC with the aim to provide critical insights into the relative benefits of each approach, thereby guiding clinical practice and decision-making. We focused on outcomes that were not necessarily restricted to preterm birth but extended to other foetal and maternal outcomes.
Methodological procedures
Article search and screening criteria
PubMed, Web of Science, Scopus, and Embase databases were screened. Studies published until 30th April 2024 were eligible for consideration. Specific keywords were used: (“pregnancy outcomes” OR “maternal-fetal outcomes” OR “perinatal outcomes” OR “preterm labor” OR “premature birth” OR “obstetric complications”) AND (“history-indicated cervical cerclage” OR “ultrasound-indicated cervical cerclage” OR “ultrasound-guided cervical cerclage”) AND (“cervical incompetence” OR “cervical insufficiency”). The PRISMA guidelines were followed [8].
Population (P): Pregnant individuals with singleton pregnancies and a documented indication for cervical cerclage, based either on historical obstetric data or ultrasonographic findings.
Intervention (I): History-Indicated Cerclage (HIC) – placement of cerclage based on prior obstetric history.
Comparison (C): Ultrasound-Indicated Cerclage (UIC) – placement of cerclage based on ultrasonographic evidence, such as cervical shortening.
Outcomes (O): At least one of the following pregnancy outcomes:
- Preterm birth
- Gestational age at delivery
- Foetal/perinatal mortality
- Birth weight
- Other relevant maternal and neonatal outcomes
Study design
Randomized controlled trials (RCTs) and observational studies (e.g., cohort and case-control studies) were eligible. Studies with either adjusted or unadjusted effect sizes were included. We included both RCTs and observational studies to ensure a comprehensive synthesis of the available evidence, as the clinical nature of cervical cerclage and ethical considerations often limit the feasibility of conducting RCTs for all subtypes. Observational studies provide valuable real-world data on the effectiveness and safety of cerclage types across diverse clinical populations. Including both study designs allowed for a broader and more representative understanding of the comparative outcomes associated with HIC and UIC.
Excluded: Studies solely focussing on one type of cerclage, without comparing it to the other intervention, those involving multiple gestations (e.g., twins, triplets), and those lacking sufficient outcome data or methodological rigor, such as case reports, letters, editorials, and conference abstracts.
No restrictions were placed on publication language or geographical location
Selection of studies, their data extraction and quality assessment
Studies identified by the literature search were deduplicated. Titles and abstracts of the remaining studies were scrutinized to identify those potentially relevant to the research objective. Subsequently, full texts of these potentially relevant studies were reviewed, leading to further exclusions and resulting in the final selection of studies for inclusion in the review process. Two authors (JW, LZ) independently carried out each step of this selection process to ensure reliability and accuracy.
Two authors (CX, WW) independently extracted relevant data from the final set of studies using a structured extraction form. This form was developed collaboratively through mutual discussion among the authors. The information extracted from the eligible studies was related to study identifier (author and year of publication), design, place of conduct, subject characteristics, gestational age at the time of cerclage, sample size, cervical length cut-off used for UIC, outcomes presented in the study and key findings. The quality of observational studies was assessed using the Newcastle-Ottawa Scale (NOS) [9]. For randomized controlled trials (RCTs), the Cochrane Risk of Bias (RoB 2.0) tool was used [10]. Any discrepancies or disagreements that arose during these processes were resolved through discussions.
Statistical analysis
STATA version 15.0 was used for analyses. We did not perform any imputation for missing data. Our analysis was based solely on the data as reported in the included studies. Wherever information was unavailable or not reported, those data points were excluded from the relevant analyses. Effect sizes, including odds ratios (OR) for categorical outcomes or weighted mean differences (WMD) for continuous outcomes along with their respective 95% confidence intervals (CI), were computed utilizing a random-effects model. This approach was adopted to accommodate potential variations in participant characteristics and methodological differences across the studies included in the analysis [11]. Separate analyses were conducted for observational studies and RCTs. Publication bias was assessed by funnel plots and Egger’s test [12]. P < 0.05 was considered significant.
Results
Database search identified 338 studies (S1 Fig). Of them, 55 duplicate records were removed, and the remaining 283 studies underwent screening based on their titles and abstracts. After this screening phase, 249 studies were excluded. The full texts of the remaining 34 studies were reviewed. Finally, 25 studies met the predetermined eligibility criteria and were included in the meta-analysis (S1 Fig) [13–37]. Studies contributed to an overall sample of 3909. Most studies were retrospective cohort (n = 18) (Table 1). Additionally, four studies were RCTs, two were case-control studies and one was a prospective cohort study. Most studies were from the USA (n = 8) and the United Kingdom (n = 5), followed by two studies each from Japan and Turkey. In 20 studies, the cervical length cut-off for UIC was set at <25mm (Table 1). The included cohort studies were of acceptable quality, as indicated by the mean NOS score of 7.1. Quality assessment of the 4 RCTs is presented as S2 Fig. Almost all studies either presented the non-confounder adjusted effect sizes or we had to derive the unadjusted effect sizes based on the data provided within the individual studies.
Neonatal outcomes
Compared to HIC, UIC was associated with increased risk of preterm birth (delivery prior to 37 weeks of gestation) (OR 1.48, 95% CI: 1.17, 1.88; N = 15, I2 = 40.8%) (Fig 1), and higher risk of having very to extremely preterm birth (gestation under 32 weeks) that approached statistical significance (OR 1.45, 95% CI: 0.96, 2.19; N = 15, I2 = 58.0%) (Fig 1). There was no indication of publication bias (Egger’s p-value 0.98) on funnel plot (S3A Fig). When studies with a randomized controlled design were pooled together, pooled estimates showed similar risk of preterm birth in HIC and UIC groups, i.e., < 37 weeks (OR 1.52, 95% CI: 0.65, 3.54; N = 2, I2 = 9.6%) and <32 weeks (OR 1.03, 95% CI: 0.60, 1.75; N = 4, I2 = 0.0%) (S4 Fig).
UIC was linked to the increased risk of having a child with low birth weight (<2500g) (OR 1.78, 95% CI: 1.32, 2.41; N = 6, I2 = 0.0%) and of admission to neonatal intensive care unit (OR 1.70, 95% CI: 1.27, 2.27; N = 6, I2 = 0.0%). The risk of having low APGAR score (5-minute score of less than 7) (OR 1.33, 95% CI: 0.51, 3.48; N = 3, I2 = 0.0%) and of foetal death (OR 1.21, 95% CI: 0.72, 2.02; N = 7, I2 = 0.0%) were comparable between the two groups (Fig 2). In analysis based on RCTs, risk of foetal death was similar in the two groups (OR 0.58, 95% CI: 0.26, 1.27; N = 3, I2 = 0.0%) (S4 Fig). There was no indication of publication bias on Egger’s test (p-value 0.38 for low birth weight, 0.54 for admission to NICU, 0.78 for low APGAR score and 0.32 for foetal death) as well on visual inspection of funnel plots (S3B-E Fig).
Mean gestational age (in weeks) (WMD −1.05, 95% CI: −1.67, −0.43; N = 15, I2 = 70.6%) (Fig 3) and birth weight (in grams) (WMD −192.87, 95% CI: −275.48, −110.26; N = 14, I2 = 20.8%) (Fig 4) was also lower in women who underwent UIC, compared to HIC. However, when RCTs were pooled, the mean gestational age was comparable across the two groups (WMD −0.02, 95% CI: −1.49, 1.46; N = 3, I2 = 53.8%) (S5 Fig).
Maternal outcomes
Women with UIC had increased risk of chorioamnionitis (OR 2.34, 95% CI: 1.36, 4.04; N = 4, I2 = 5.0%) and higher, but not statistically significant risk of preterm premature rupture of membrane (PPROM) (Fig 5). UIC was associated with the reduced risk of having a caesarean delivery (OR 0.76, 95% CI: 0.58, 0.99; N = 5, I2 = 0.0%) (Fig 5). There was no indication of publication bias on Egger’s test (p-value 0.28 for chorioamnionitis, 0.45 for PPROM, 0.17 for caesarean delivery) as well on visual inspection of funnel plots (S3F-H Fig).
Discussion
This study compared pregnancy outcomes of HIC and UIC, and showed that UIC was associated with higher risks of adverse pregnancy outcomes compared to HIC. Women undergoing UIC typically present with a shortened cervix during the second trimester, which may reflect an already ongoing subclinical inflammatory or infectious process or cervical insufficiency. This underlying pathology may predispose these pregnancies to preterm birth, chorioamnionitis, and subsequent neonatal complications, regardless of cerclage placement. In contrast, women in the HIC group often receive cerclage earlier in pregnancy based on obstetric history alone, before signs of cervical shortening emerge, potentially preventing cervical changes and exposure to ascending infection. Furthermore, differences in cervical tissue biology at the time of cerclage placement may influence outcomes. By the time UIC is indicated, cervical collagen remodelling and local immune responses may have already advanced, reducing the efficacy of cerclage in preventing further dilation or infection. It is also possible that in UIC, the cervix is already shortened and structurally compromised, making the surgical placement of cerclage technically more challenging and potentially less effective in maintaining cervical competence. In contrast, earlier placement in the HIC group may provide more robust mechanical support throughout gestation. In summary, the differences in baseline risk profiles, timing of intervention, and underlying pathophysiology may contribute to the observed differences in outcomes.
The observed increased risk of preterm birth among women with UIC might underscore the importance of carefully considering indications for cerclage placement. It is important to note that this finding is contrary to the previous review by Blikman et al that found no differences in risk of preterm birth between UIC and HIC [7]. However, the review by Blikman et al. included limited number of studies (n = 6) whereas, the current review summarized data from much larger number of reports. This observed increased risk of preterm births prompts exploration into potential biological mechanisms that may explain the association. One plausible explanation could be related to the selection bias inherent in ultrasound-based indications. Ultrasound screening is able to detect even most subtle cervical changes that may indicate impending preterm labour [38], and timely identify underlying pathological processes such as cervical inflammation or cervical insufficiency. On the other hand, historical indications may capture a broader spectrum of risk factors, potentially leading to more effective risk estimation [39,40]. Further studies of the molecular pathways underlying cervical remodelling and inflammation may shed light on the differential effectiveness of cerclage indications.
Furthermore, the observed association between UIC and higher risk of adverse neonatal outcomes, including low birth weight and admission to the neonatal intensive care unit, highlights the potential clinical implications of cerclage indication and should be confirmed in future studies. Our findings emphasize the need for careful patient selection and counselling regarding risks and benefits of cerclage placement. Interestingly, our analysis revealed a reduced risk of caesarean delivery among women with UIC. While the reasons for this finding are not entirely clear, it might be attributed to differences in cervical length screening protocols, patient characteristics, or obstetric management strategies between the two groups. The observed increased risk of maternal complications, including chorioamnionitis and preterm premature rupture of membranes (PPROM), among women with UIC raises important considerations regarding the potential impact of cerclage indication on maternal health. Our findings underscore the importance of comprehensive maternal risk assessment and close monitoring during pregnancy following cerclage placement.
The lack of significant differences between the two groups when RCTs were pooled could be attributed to several important factors. Firstly, RCTs are considered the gold standard for evaluating interventions, as they minimize bias and confounding variables through randomization. In the case of cerclage indications, RCTs may have implemented strict inclusion criteria and standardized protocols, resulting in less biased outcomes between HIC and UIC groups. Additionally, there is a possibility that due to the small sample sizes of RCTs, the statistical power to detect significant differences between the groups was limited. Further research, including larger RCTs with standardized protocols and long-term follow-up, may help elucidate the differential effects of HIC and UIC on pregnancy outcomes
Clinicians should carefully weigh the risks and benefits of different cerclage indications, considering individual patient characteristics and obstetric history. While ultrasound screening may offer valuable insights into cervical dynamics, close monitoring and multidisciplinary management are essential to mitigate the risks of adverse neonatal and maternal outcomes associated with UIC. Future research should focus on elucidating the underlying biological mechanisms of the observed associations. Prospective studies, preferably clinical trials, with standardized protocols, comprehensive outcome assessments and adequate statistical analysis are needed to provide robust evidence for clinical decision-making.
Our review has several limitations. The most important limitation is the use of non-confounder-adjusted effect sizes from individual studies which may have led to pooled effect sizes that do not reflect the true association. The retrospective nature of studies may have introduced a bias. Additionally, limited number of RCTs included in our analysis may have affected the precision of our estimates. It is important to note that while our review compares outcomes between UIC and HIC, these interventions are applied in distinct clinical contexts: UIC is typically used as an emergency measure based on cervical shortening or funneling, where the interval between cerclage placement and delivery is a key prognostic factor, whereas HIC is a preventive intervention based on obstetric history, with gestational age at delivery being more relevant to assess effectiveness. Therefore, while comparisons provide insights into relative outcomes, the two groups are not directly comparable due to these fundamental differences in indication and timing. Further, although sub-classifying the UIC group based on cervical length thresholds (e.g., < 20 mm, < 15 mm, or open cervix) may have provided more granular insights, this was not feasible due to limitations in the available data. In our review, 20 out of 25 studies used a uniform cervical length cut-off of <25 mm, while only 3 studies used a stricter threshold of <20 mm. The lack of variation in the cut-off used precluded a reliable subgroup analysis. We acknowledge that our search did not include clinical trial registries or grey literature sources. We chose to focus on peer-reviewed, published literature to ensure the inclusion of studies with sufficient methodological rigor and outcome reporting. While we recognize that grey literature and trial registries can reduce publication bias, our priority was to maintain the quality and reliability of data for meta-analysis. In addition, while most outcomes in our analysis showed low heterogeneity (I2 < 50%), moderate heterogeneity was noted for very to extreme preterm birth and mean gestational age. This likely reflects differences in gestational age assessment methods across studies, particularly the limited use of early pregnancy ultrasonography in some settings. Variation in study populations and healthcare contexts may also have contributed. Lastly, we did not conduct a GRADE assessment. However, the certainty of evidence is likely to be low, given that most of the included studies were observational in nature and did not adjust for potential confounders.
Conclusion
Our findings from pooling of non-confounder-adjusted estimates suggest that the mode of indication for cervical cerclage placement may influence pregnancy and maternal outcomes in women with a history of preterm delivery. Future studies should explore reliability and validity of our findings through adoption of robust methodology, including adjustment for important confounders, and also focus on elucidating the underlying mechanisms driving the associations. Ultimately, a personalized approach to cerclage indication and obstetric management tailored to individual patient characteristics and risk profiles may optimize pregnancy outcomes in this high-risk population.
Supporting information
S1 Fig. PRISMA flowchart to show process of study selection.
https://doi.org/10.1371/journal.pone.0328564.s001
(PDF)
S2 Fig. Assessment of quality of randomized controlled trials, using the RoB2.0 tool.
https://doi.org/10.1371/journal.pone.0328564.s002
(TIF)
S3 Fig. Funnel plot for assessment of publication bias in relation to risk of A) preterm delivery; B) low birth weight baby; C) admission to NICU; D) low APGAR score; E) foetal death; F) chorioamnionitis; G) PPROM; H) caesarean delivery.
https://doi.org/10.1371/journal.pone.0328564.s003
(PDF)
S4 Fig. Risk of preterm birth in those undergoing ultrasound-indicated cerclage, compared to history-indicated cerclage, in studies with randomized controlled design.
https://doi.org/10.1371/journal.pone.0328564.s004
(TIF)
S5 Fig. Comparison of mean gestational age (in weeks) among ultrasound-indicated cerclage and history-indicated cerclage, in studies with randomized controlled design.
https://doi.org/10.1371/journal.pone.0328564.s005
(TIF)
S1 File. Retrieved studies after removing duplicates.
https://doi.org/10.1371/journal.pone.0328564.s006
(XLS)
References
- 1. Simcox R, Shennan A. Cervical cerclage: a review. Int J Surg. 2007;5(3):205–9. pmid:17509504
- 2. Giouleka S, Boureka E, Tsakiridis I, Siargkas A, Mamopoulos A, Kalogiannidis I, et al. Cervical cerclage: a comprehensive review of major guidelines. Obstet Gynecol Surv. 2023;78(9):544–53. pmid:37976303
- 3. Alfirevic Z, Stampalija T, Medley N. Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy. Cochrane Database Syst Rev. 2017;6(6):CD008991. pmid:28586127
- 4. RUTANEN E. Cerclage in cervical insufficiency: when and to whom?. Acta Obstet Gynecol Scand. 2007;86(4):387–8.
- 5. Shennan A, Story L, Jacobsson B, Grobman WA, FIGO Working Group for Preterm Birth. FIGO good practice recommendations on cervical cerclage for prevention of preterm birth. Int J Gynaecol Obstet. 2021;155(1):19–22. pmid:34520055
- 6. Berghella V, Mackeen AD. Cervical length screening with ultrasound-indicated cerclage compared with history-indicated cerclage for prevention of preterm birth: a meta-analysis. Obstet Gynecol. 2011;118(1):148–55. pmid:21691173
- 7. Blikman MJC, Le T-M, Bruinse HW, van der Heijden GJMG. Ultrasound-Predicated Versus History-Predicated Cerclage in Women at Risk of Cervical Insufficiency. Obstetrical & Gynecological Survey. 2008;63(12):803–12.
- 8. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. pmid:33782057
- 9.
Wells G, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. [cited 2023 November 18]. https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
- 10. Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. pmid:31462531
- 11.
Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M, Welch V. Cochrane Handbook for Systematic Reviews of Interventions. [cited November 18, 2023]. https://training.cochrane.org/handbook
- 12. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.
- 13. Ikechebelu JI, Dim CC, Okpala BC, Eleje GU, Joe-Ikechebelu NN, Malachy DE, et al. Comparison of Pregnancy Outcomes of History-Indicated and Ultrasound-Indicated Cervical Cerclage: A Retrospective Cohort Study. Biomed Res Int. 2023;2023:8782854. pmid:36654867
- 14. Mullin J, O’Sullivan HR, Shennan AH, Suff N. Outcomes following elective cerclage versus ultrasound surveillance in women with one prior preterm event. Eur J Obstet Gynecol Reprod Biol. 2023;290:1–4. pmid:37708656
- 15. Adekola H, Addo J, Unal ER, James E, Prakash V, Abrams R. Outcomes following Placement and Removal of Transvaginal Cerclage in at Risk Pregnancies: A Single Center Experience. Journal of Pregnancy. 2022;2022:1–6.
- 16. Seyama R, Makino S, Takeda J, Takeda S, Itakura A. The retrospective study for effectiveness of cervical cerclage in preventing recurrent preterm birth. Taiwan J Obstet Gynecol. 2022;61(1):63–9. pmid:35181048
- 17. Golbasi C, Golbasi H, Bayraktar B, Sever B, Vural T, Ekin A. Effectiveness and perinatal outcomes of history-indicated, ultrasound-indicated and physical examination-indicated cerclage: a retrospective study. BMC Pregnancy Childbirth. 2022;22(1).
- 18. Kuruma A, Hayashi S, Koh I, Yamamoto R, Mitsuda N, Ishii K. Incidences of complications associated with cervical cerclage by indication of the procedure. J Obstet Gynaecol Res. 2022;48(1):73–9. pmid:34729864
- 19. Yüksel Şimşek S, Şimşek E, Doğan Durdağ G, Alemdaroğlu S, Baran ŞY, Kalaycı H. Prevention of preterm delivery by cervical cerclage; a comparison of prophylactic and emergency procedures. J Turkish German Gynecol Assoc. 2021;22(1):22–8.
- 20. Chen R, Huang X, Li B. Pregnancy outcomes and factors affecting the clinical effects of cervical cerclage when used for different indications: A retrospective study of 326 cases. Taiwanese Journal of Obstetrics and Gynecology. 2020;59(1):28–33.
- 21. Battarbee AN, Ellis JS, Manuck TA. Beyond Cervical Length: Association between Postcerclage Transvaginal Ultrasound Parameters and Preterm Birth. Am J Perinatol. 2019;36(13):1317–24. pmid:31039598
- 22. Story L, Shennan A. An assessment of mode of delivery in history indicated versus ultrasound indicated vaginally placed cervical cerclage. Eur J Obstet Gynecol Reprod Biol. 2017;210:123–5. pmid:28012405
- 23. Suhag A, Seligman N, Giraldo-Isaza M, Berghella V. Pre-pregnancy body mass index (BMI) and cerclage success. J Matern Fetal Neonatal Med. 2016;29(3):368–75. pmid:25633535
- 24. Chan LLK, Leung TW, Lo TK, Lau WL, Leung WC. Indications for and pregnancy outcomes of cervical cerclage: 11-year comparison of patients undergoing history-indicated, ultrasound-indicated, or rescue cerclage. Hong Kong Med J. 2015;21(4):310–7. pmid:26183455
- 25. Kuon R-J, Hudalla H, Seitz C, Hertler S, Gawlik S, Fluhr H, et al. Impaired Neonatal Outcome after Emergency Cerclage Adds Controversy to Prolongation of Pregnancy. PLoS One. 2015;10(6):e0129104. pmid:26121653
- 26. Giraldo-Isaza MA, Fried GP, Hegarty SE, Suescum-Diaz MA, Cohen AW, Berghella V. Comparison of 2 stitches vs 1 stitch for transvaginal cervical cerclage for preterm birth prevention. Am J Obstet Gynecol. 2013;208(3):209.e1-9. pmid:23201330
- 27. Drassinower D, Poggi SH, Landy HJ, Gilo N, Benson JE, Ghidini A. Perioperative complications of history-indicated and ultrasound-indicated cervical cerclage. Am J Obstet Gynecol. 2011;205(1):53.e1-5. pmid:22088898
- 28. Nelson L, Dola T, Tran T, Carter M, Luu H, Dola C. Pregnancy outcomes following placement of elective, urgent and emergent cerclage. J Matern Fetal Neonatal Med. 2009;22(3):269–73. pmid:19330713
- 29. Simcox R, Seed PT, Bennett P, Teoh TG, Poston L, Shennan AH. A randomized controlled trial of cervical scanning vs history to determine cerclage in women at high risk of preterm birth (CIRCLE trial). Am J Obstet Gynecol. 2009;200(6):623.e1-6. pmid:19380124
- 30. Beigi A. Elective versus ultrasound-indicated cervical cerclage in women at risk for cervical incompetence. Medical Journal of the Islamic Republic of Iran. 2005;19:103–7.
- 31. Groom KM, Bennett PR, Golara M, Thalon A, Shennan AH. Elective cervical cerclage versus serial ultrasound surveillance of cervical length in a population at high risk for preterm delivery. Eur J Obstet Gynecol Reprod Biol. 2004;112(2):158–61. pmid:14746951
- 32. Higgins SP, Kornman LH, Bell RJ, Brennecke SP. Cervical surveillance as an alternative to elective cervical cerclage for pregnancy management of suspected cervical incompetence. Aust N Z J Obstet Gynaecol. 2004;44(3):228–32. pmid:15191447
- 33. Berghella V, Haas S, Chervoneva I, Hyslop T. Patients with prior second-trimester loss: prophylactic cerclage or serial transvaginal sonograms?. Am J Obstet Gynecol. 2002;187(3):747–51. pmid:12237658
- 34. To MS, Palaniappan V, Skentou C, Gibb D, Nicolaides KH. Elective cerclage vs. ultrasound-indicated cerclage in high-risk pregnancies. Ultrasound Obstet Gynecol. 2002;19(5):475–7. pmid:11982981
- 35. Kassanos D, Salamalekis E, Vitoratos N, Panayotopoulos N, Loghis C, Creatsas C. The value of transvaginal ultrasonography in diagnosis and management of cervical incompetence. Clin Exp Obstet Gynecol. 2001;28(4):266–8. pmid:11838756
- 36. Kelly S, Pollock M, Maas B, Lefebvre C, Manley J, Sciscione A. Early transvaginal ultrasonography versus early cerclage in women with an unclear history of incompetent cervix. Am J Obstet Gynecol. 2001;184(6):1097–9. pmid:11349168
- 37. Althuisius SM, Dekker GA, van Geijn HP, Bekedam DJ, Hummel P. Cervical incompetence prevention randomized cerclage trial (CIPRACT): study design and preliminary results. Am J Obstet Gynecol. 2000;183(4):823–9. pmid:11035320
- 38. Rozenberg P, Gillet A, Ville Y. Transvaginal sonographic examination of the cervix in asymptomatic pregnant women: review of the literature. Ultrasound Obstet Gynecol. 2002;19(3):302–11. pmid:11896957
- 39.
Bieber KB, Olson SM. “Cervical Cerclage.,” StatPearls. Treasure Island (FL): StatPearls Publishing; 2024. [Accessed July 3, 2024. ]. http://www.ncbi.nlm.nih.gov/books/NBK560523/
- 40. Okusanya BO, Isabu PA. Outcome of pregnancy with history-indicated cervical cerclage insertion in a low-resource setting. J Matern Fetal Neonatal Med. 2015;28(3):284–7. pmid:24735487